Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Henry Halliday

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Living Beings

Newborn Infant

Concepts & Ideas

Disorders

Chemicals & Drugs

Procedures

Physiology

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
18
Sweet, David
9
Curley, Anna
6
Ehrenkranz, RA
6
Lappin, Terence
6
Warner, Jane
4
Speer, Christian
4
Harms, Karsten
4
Herting, Egbert
4
Grier, David
3
Gefeller, Olaf
3
Ehrenkranz, RA
3
Elbourne, Diana
3
Ahluwalia, Jag
3
Tomlin, K
3
Doyle, LW

Sign-in to see all Coauthors

Publications

TOP 3
Sweet D G; Halliday H L
The use of surfactants in 2009.
Grier David G; Thompson Alexander; Lappin Terence R J; Halliday Henry L
Quantification of Hox and surfactant protein-B transcription during murine lung development.
Halliday H L
Surfactants: past, present and future.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Henry Halliday (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Sweet D G; Halliday H L
The use of surfactants in 2009.
Archives of disease in childhood. Education and practice edition 2009;94(3):78-83.
2009: Grier David G; Thompson Alexander; Lappin Terence R J; Halliday Henry L
Quantification of Hox and surfactant protein-B transcription during murine lung development.
Neonatology 2009;96(1):50-60.
2008: Halliday H L
Surfactants: past, present and future.
Journal of perinatology : official journal of the California Perinatal Association 2008;28 Suppl 1():S47-56.
2008: Murphy Christine A; Cupples Margaret E; Percy Andrew; Halliday Henry L; Stewart Moira C
Peer-mentoring for first-time mothers from areas of socio-economic disadvantage: a qualitative study within a randomised controlled trial.
BMC health services research 2008;8():46.
2008: Sweet David G; Huggett Matthew T; Warner Jane A; Moss Timothy J M; Kloosterboer Nico; Halliday Henry L; Newnham John P; Kallapur Suhas G; Jobe Alan H; Kramer Boris W
Maternal betamethasone and chorioamnionitis induce different collagenases during lung maturation in fetal sheep.
Neonatology 2008;94(2):79-86.
2008: Valls-i-Soler A; Carnielli V; Claris O; de la Cruz Bértolo J; Halliday H L; Hallman M; Hummler H; Weindling M;
EuroNeoStat: a European information system on the outcomes of care for very-low-birth-weight infants.
Neonatology 2008;93(1):7-9.
2007: Verner Alison Maria; Manderson John; Lappin Terrence R J; McCance David R; Halliday Henry L; Sweet David G
Influence of maternal diabetes mellitus on fetal iron status.
Archives of disease in childhood. Fetal and neonatal edition 2007;92(5):F399-401.
2007: Spence Dale; Alderdice Fiona A; Stewart Moira C; Halliday Henry L; Bell Angela H
Does intrauterine growth restriction affect quality of life in adulthood?
Archives of disease in childhood 2007;92(8):700-3.
2007: Sweet David; Bevilacqua Giulio; Carnielli Virgilio; Greisen Gorm; Plavka Richard; Saugstad Ola Didrik; Simeoni Umberto; Speer Christian P; Valls-I-Soler Adolf; Halliday Henry; Working Group on Prematurity of the World Association of Perinatal Medicine; European Association of Perinatal Medicine
European consensus guidelines on the management of neonatal respiratory distress syndrome.
Journal of perinatal medicine 2007;35(3):175-86.
2007: Field D; Elbourne D; Hardy P; Fenton A C; Ahluwalia J; Halliday H L; Subhedar N; Heinonen K; Aikio O; Grieve R; Truesdale A; Tomlin K; Normand C; Stocks J;
Neonatal ventilation with inhaled nitric oxide vs. ventilatory support without inhaled nitric oxide for infants with severe respiratory failure born at or near term: the INNOVO multicentre randomised controlled trial.
Neonatology 2007;91(2):73-82.
2006: Ahluwalia J; Tooley J; Cheema I; Sweet D G; Curley A E; Halliday H L; Field D; Al'malik H; Annamalai S; Midgley P; Hardy P; Tomlin K; Elbourne D
A dose response study of inhaled nitric oxide in hypoxic respiratory failure in preterm infants.
Early human development 2006;82(7):477-83.
2006: Wilson Trevor T; Waters Lorraine; Patterson Chris C; McCusker Chris G; Rooney Nichola M; Marlow Neil; Halliday Henry L
Neurodevelopmental and respiratory follow-up results at 7 years for children from the United Kingdom and Ireland enrolled in a randomized trial of early and late postnatal corticosteroid treatment, systemic and inhaled (the Open Study of Early Corticosteroid Treatment).
Pediatrics 2006;117(6):2196-205.
2006: Lappin Terence R J; Grier David G; Thompson Alexander; Halliday Henry L
HOX genes: seductive science, mysterious mechanisms.
The Ulster medical journal 2006;75(1):23-31.
2006: Halliday Henry L
Recent clinical trials of surfactant treatment for neonates.
Biology of the neonate 2006;89(4):323-9.
2005: Field D; Elbourne D; Truesdale A; Grieve R; Hardy P; Fenton A C; Subhedar N; Ahluwalia J; Halliday H L; Stocks J; Tomlin K; Normand C;
Neonatal Ventilation With Inhaled Nitric Oxide Versus Ventilatory Support Without Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failure: the INNOVO multicentre randomised controlled trial (ISRCTN 17821339).
Pediatrics 2005;115(4):926-36.
2005: Halliday Henry L
Evidence-based neonatal care.
Best practice & research. Clinical obstetrics & gynaecology 2005;19(1):155-66.
2005: Grier D G; Thompson A; Kwasniewska A; McGonigle G J; Halliday H L; Lappin T R
The pathophysiology of HOX genes and their role in cancer.
The Journal of pathology 2005;205(2):154-71.
2005: Sweet David G; Halliday Henry L
Modeling and remodeling of the lung in neonatal chronic lung disease: implications for therapy.
Treatments in respiratory medicine 2005;4(5):347-59.
2005: Halliday Henry L
History of surfactant from 1980.
Biology of the neonate 2005;87(4):317-22.
2005: McCall E M; Alderdice F A; Halliday H L; Jenkins J G; Vohra S
Interventions to prevent hypothermia at birth in preterm and/or low birthweight babies.
Cochrane database of systematic reviews (Online) 2005;(1):CD004210.
2005: Grier David G; Halliday Henry L
Management of bronchopulmonary dysplasia in infants: guidelines for corticosteroid use.
Drugs 2005;65(1):15-29.
2004: Sweet D G; Curley A E; Chesshyre E; Pizzotti J; Wilbourn M S; Halliday H L; Warner J A
The role of matrix metalloproteinases -9 and -2 in development of neonatal chronic lung disease.
Acta paediatrica (Oslo, Norway : 1992) 2004;93(6):791-6.
2004: Curley A E; Sweet D G; MacMahon K J; O'Connor C M; Halliday H L
Chorioamnionitis increases matrix metalloproteinase-8 concentrations in bronchoalveolar lavage fluid from preterm babies.
Archives of disease in childhood. Fetal and neonatal edition 2004;89(1):F61-4.
2004: Grier David G; Halliday Henry L
Effects of glucocorticoids on fetal and neonatal lung development.
Treatments in respiratory medicine 2004;3(5):295-306.
2004: Halliday Henry L
Airway proteins--surfactants.
Pediatric pulmonology. Supplement 2004;26():143-6.
2004: Halliday Henry L
Prevention strategies of chronic lung disease.
Pediatric pulmonology. Supplement 2004;26():103-5.
2004: Halliday Henry L
Postnatal steroids and chronic lung disease in the newborn.
Paediatric respiratory reviews 2004;5 Suppl A():S245-8.
2003: Halliday H L
Postnatal dexamethasone: what is the real cost-benefit ratio?
Acta paediatrica (Oslo, Norway : 1992) 2003;92(8):888-9.
2003: Curley Anna E; Sweet David G; Thornton Claire M; O'Hara M Denis; Chesshyre Emily; Pizzotti Jessica; Wilbourn Mark S; Halliday Henry L; Warner Jane A
Chorioamnionitis and increased neonatal lung lavage fluid matrix metalloproteinase-9 levels: implications for antenatal origins of chronic lung disease.
American journal of obstetrics and gynecology 2003;188(4):871-5.
2003: Grier David G; Halliday Henry L
Corticosteroids in the prevention and management of bronchopulmonary dysplasia.
Seminars in neonatology : SN 2003;8(1):83-91.
2003: Halliday H L; Ehrenkranz R A; Doyle L W
Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants.
Cochrane database of systematic reviews (Online) 2003;(1):CD001146.
2003: Halliday H L; Ehrenkranz R A; Doyle L W
Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants.
Cochrane database of systematic reviews (Online) 2003;(1):CD001145.
2003: Halliday H L; Ehrenkranz R A; Doyle L W
Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants.
Cochrane database of systematic reviews (Online) 2003;(1):CD001144.
2002: Sweet D G; Halliday H L; Warner J A
Case 4: assessment. Early chronic lung disease.
Paediatric respiratory reviews 2002;3(2):162, 164-5.
2002: Sweet David G; Halliday Henry L; Warner Jane A
Airway remodelling in chronic lung disease of prematurity.
Paediatric respiratory reviews 2002;3(2):140-6.
2002: Halliday Henry L
Early postnatal dexamethasone and cerebral palsy.
Pediatrics 2002;109(6):1168-9.
2002: Mayes C; Yarr J; Spence D; Tubman R; Halliday H L
Neonatal seizures-management and outcome in a regional unit.
Irish medical journal 2002;95(4):122-3.
2001: Schock B C; Sweet D G; Ennis M; Warner J A; Young I S; Halliday H L
Oxidative stress and increased type-IV collagenase levels in bronchoalveolar lavage fluid from newborn babies.
Pediatric research 2001;50(1):29-33.
2001: Sweet D G; Savage G A; Tubman R; Lappin T R; Halliday H L
Cord blood transferrin receptors to assess fetal iron status.
Archives of disease in childhood. Fetal and neonatal edition 2001;85(1):F46-8.
2001: Curley A E; Halliday H L
Evidence-based practice: does it have a role in paediatrics?
Irish medical journal 2001;94(5):133-4.
2001: Bedford Russell A R; Emmerson A J; Wilkinson N; Chant T; Sweet D G; Halliday H L; Holland B; Davies E G
A trial of recombinant human granulocyte colony stimulating factor for the treatment of very low birthweight infants with presumed sepsis and neutropenia.
Archives of disease in childhood. Fetal and neonatal edition 2001;84(3):F172-6.
2001: Sweet D G; McMahon K J; Curley A E; O'Connor C M; Halliday H L
Type I collagenases in bronchoalveolar lavage fluid from preterm babies at risk of developing chronic lung disease.
Archives of disease in childhood. Fetal and neonatal edition 2001;84(3):F168-71.
2001: Curley A E; Halliday H L
The present status of exogenous surfactant for the newborn.
Early human development 2001;61(2):67-83.
2001: Halliday H L
Postnatal steroids: a dilemma for the neonatologist.
Acta paediatrica (Oslo, Norway : 1992) 2001;90(2):116-8.
2001: Halliday H L; Patterson C C; Halahakoon C W;
A multicenter, randomized open study of early corticosteroid treatment (OSECT) in preterm infants with respiratory illness: comparison of early and late treatment and of dexamethasone and inhaled budesonide.
Pediatrics 2001;107(2):232-40.
2001: Sweet D G; Savage G; Tubman T R; Lappin T R; Halliday H L
Study of maternal influences on fetal iron status at term using cord blood transferrin receptors.
Archives of disease in childhood. Fetal and neonatal edition 2001;84(1):F40-3.
2001: Halliday H L
The effect of postnatal steroids on growth and development.
Journal of perinatal medicine 2001;29(4):281-5.
2001: Halliday H L; Ehrenkranz R A
Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants.
Cochrane database of systematic reviews (Online) 2001;(2):CD001145.
2001: Halliday H L; Ehrenkranz R A
Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants.
Cochrane database of systematic reviews (Online) 2001;(1):CD001146.
2001: Halliday H L; Ehrenkranz R A
Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants.
Cochrane database of systematic reviews (Online) 2001;(1):CD001144.
2001: Halliday H L
Endotracheal intubation at birth for preventing morbidity and mortality in vigorous, meconium-stained infants born at term.
Cochrane database of systematic reviews (Online) 2001;(1):CD000500.
2000: Curley A E; Tubman T R; Halliday H L
[Treatment of very low birth weight infant: is it evidenced-based?]
Anales españoles de pediatría 2000;52(6):554-60.
2000: Curley A E; Halliday H L
[Evidence-based paediatrics]
Anales españoles de pediatría 2000;52(6):497-500.
2000: Halliday H L; Ehrenkranz R A
Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants.
Cochrane database of systematic reviews (Online) 2000;(2):CD001144.
2000: Halliday H L; Ehrenkranz R A
Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants.
Cochrane database of systematic reviews (Online) 2000;(2):CD001146.
2000: Halliday H L; Ehrenkranz R A
Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants.
Cochrane database of systematic reviews (Online) 2000;(2):CD001145.
2000: Halliday H L
Endotracheal intubation at birth for preventing morbidity and mortality in vigorous, meconium-stained infants born at term.
Cochrane database of systematic reviews (Online) 2000;(2):CD000500.
1999: Halliday H L
Clinical trials of postnatal corticosteroids: inhaled and systemic.
Biology of the neonate 1999;76 Suppl 1():29-40.
1999: Sweet D G; Hadden D; Halliday H L
The effect of early feeding on the neonatal blood glucose level at 1-hour of age.
Early human development 1999;55(1):63-6.
1999: Cairns P A; McClure B G; Halliday H L; Mc Reid M
Unusual site for oesophageal perforation in an extremely low birth weight infant.
European journal of pediatrics 1999;158(2):152-3.
1999: Sweet D G; Halliday H L
Current perspectives on the drug treatment of neonatal respiratory distress syndrome.
Paediatric drugs 1999;1(1):19-30.
1999: Halliday H L
Systematic reviews in perinatal medicine.
Journal of perinatal medicine 1999;27(1):41-4.
1998: Halliday H L
Which interventions for neonatal respiratory failure are effective?
Croatian medical journal 1998;39(2):165-70.
1998: McKillop A M; O'Hare M M; Craig J S; Dodge J A; Halliday H L
Incidence of molecular forms of bile salt-stimulated lipase in preterm and term human milk.
Pediatric research 1998;43(1):101-4.
1998: Sweet D G; Craig B; Halliday H L; Mulholland C
Gastro-intestinal complications following neonatal cardiac catheterisation.
Journal of perinatal medicine 1998;26(3):196-200.
1997: O'Hare M M; Bingham A M; McMaster C; Halahakoon W L; Corcoran J D; Halliday H L
Lyso-phosphatidylcholine and outcome of preterm babies with respiratory distress syndrome treated with surfactant.
Early human development 1997;49(2):135-41.
1997: Wilson D C; Cairns P; Halliday H L; Reid M; McClure G; Dodge J A
Randomised controlled trial of an aggressive nutritional regimen in sick very low birthweight infants.
Archives of disease in childhood. Fetal and neonatal edition 1997;77(1):F4-11.
1997: Elasoud K; McClure G; Halliday H L; Dornan J C
Rhesus haemolytic disease of the newborn, complicating a quadruplet pregnancy.
The Ulster medical journal 1997;66(1):62-4.
1997: Halliday H L
Synthetic or natural surfactants.
Acta paediatrica (Oslo, Norway : 1992) 1997;86(3):233-7.
1997: Halliday H L
Clinical trials of surfactant replacement in Europe.
Biology of the neonate 1997;71 Suppl 1():8-12.
1996: Halliday H L; Speer C P; Robertson B
Treatment of severe meconium aspiration syndrome with porcine surfactant. Collaborative Surfactant Study Group.
European journal of pediatrics 1996;155(12):1047-51.
1996: Halliday H L
Natural vs synthetic surfactants in neonatal respiratory distress syndrome.
Drugs 1996;51(2):226-37.
1995: Cairns P A; Wilson D C; McClure B G; Halliday H L; McReid M
Percutaneous central venous catheter use in the very low birth weight neonate.
European journal of pediatrics 1995;154(2):145-7.
1995: Halliday H L
Overview of clinical trials comparing natural and synthetic surfactants.
Biology of the neonate 1995;67 Suppl 1():32-47.
1994: Herting E; Gefeller O; Speer C P; Harms K; Halliday H L; Curstedt T; Robertson B
Intracerebral haemorrhages in surfactant treated neonates with severe respiratory distress syndrome: age at diagnosis, severity and risk factors.
European journal of pediatrics 1994;153(11):842-9.
1993: Herting E; Tubman R; Halliday H L; Harms K; Speer C P; Curstedt T; Robertson B
[Effect of 2 different dosages of a porcine surfactant on pulmonary gas exchange of premature infants with severe respiratory distress syndrome]
Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft für Kinderheilkunde 1993;141(9):721-7.
1992: Rankin S J; Tubman T R; Halliday H L; Johnston S S
Retinopathy of prematurity in surfactant treated infants.
The British journal of ophthalmology 1992;76(4):202-4.
1992: Speer C P; Robertson B; Curstedt T; Halliday H L; Compagnone D; Gefeller O; Harms K; Herting E; McClure G; Reid M
Randomized European multicenter trial of surfactant replacement therapy for severe neonatal respiratory distress syndrome: single versus multiple doses of Curosurf.
Pediatrics 1992;89(1):13-20.
1992: Wilson D C; Tubman T R; Halliday H L; McMaster D
Plasma manganese levels in the very low birth weight infant are high in early life.
Biology of the neonate 1992;61(1):42-6.
1992: Tubman T R; Rankin S J; Halliday H L; Johnston S S
Surfactant replacement therapy and the prevalence of acute retinopathy of prematurity.
Biology of the neonate 1992;61 Suppl 1():54-8.
1992: Herting E; Speer C P; Harms K; Robertson B; Curstedt T; Halliday H L; Compagnone D; Gefeller O; McClure G; Reid M
Factors influencing morbidity and mortality in infants with severe respiratory distress syndrome treated with single or multiple doses of a natural porcine surfactant.
Biology of the neonate 1992;61 Suppl 1():26-30.
1991: Wilson D C; Tubman R; Bell N; Halliday H L; McMaster D
Plasma manganese, selenium and glutathione peroxidase levels in the mother and newborn infant.
Early human development 1991;26(3):223-6.
1991: Rankin S J; Tubman T R; Halliday H L; Johnston S S
Surfactant and ROP incidence.
Ophthalmology 1991;98(8):1148-9.
1991: Sittlington N; Tubman R; Halliday H L
Surfactant replacement therapy for severe neonatal respiratory distress syndrome: implications for nursing care.
Midwifery 1991;7(1):20-4.
1991: Tubman T R; Rollins M D; Patterson C; Halliday H L
Increased incidence of respiratory distress syndrome in babies of hypertensive mothers.
Archives of disease in childhood 1991;66(1 Spec No):52-4.
1991: Wilson D C; Tubman T R; Bell N; Halliday H L; McMaster D
Effect of blood transfusion on plasma selenium, glutathione peroxidase and manganese levels in very low birth weight infants.
Biology of the neonate 1991;60(3-4):148-51.
1991: Tubman T R; Halliday H L; Normand C
Economic impact of porcine surfactant replacement (Curosurf) for severe neonatal respiratory distress syndrome.
Journal of perinatal medicine 1991;19 Suppl 1():403-7.
1990: Tubman T R; Halliday H L; Normand C
Cost of surfactant replacement treatment for severe neonatal respiratory distress syndrome: a randomised controlled trial.
BMJ (Clinical research ed.) 1990;301(6756):842-5.
1990: Tubman T R; Halliday H L; McMaster D
Glutathione peroxidase and selenium levels in the preterm infant.
Biology of the neonate 1990;58(6):305-10.
1989: Halliday H L
Clinical experience with exogenous natural surfactant.
Developmental pharmacology and therapeutics 1989;13(2-4):173-81.

Sign-in to see more